Brevan Howard Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,147	Closed	-$316K	–	1353
2024 Q4	$316K	Buy	25,147 +8,427	+50%	+$106K	﹤0.01%	725
2024 Q3	$309K	Buy	+16,720	New	+$309K	﹤0.01%	792